GSA Capital Partners LLP cut its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 62.9% in the ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made ...

On Monday, ACADIA Pharmaceuticals Inc (ACAD) stock saw a decline, ending the day at $14.62 which represents a decrease of $-0.19 or -1.28% from the prior close of $14.81. The stock opened at $14.73 ...

Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow ... Momentum investors should take note of this Medical stock. ACAD has a Momentum Style Score of B, and shares are up 21.9% over ...

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

J.P. Morgan analyst Tessa Romero has maintained their bullish stance on ACAD stock, giving a Buy rating today. Tessa Romero has given her Buy ...

In a report released today, Jay Olson from Oppenheimer maintained a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report), with ...